lipoxin a4 has been researched along with Heart Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexanderson-Rosas, E; Amezcua-Guerra, LM; Azar-Manzur, F; Bojalil, R; Brianza-Padilla, M; Carvajal-Juárez, I; González-Pacheco, H; Gopar-Nieto, R; Hernández, S; López-Mora, E; Márquez-Velasco, R; Martínez-Sánchez, C; Massó, F; Paez-Arenas, A; Sandoval, J; Venegas-Román, A | 1 |
| Afonso, J; Albino-Teixeira, A; Bettencourt, P; Carvalho, F; Carvalho, J; Reina-Couto, M; Sousa, T; Vale, L; Valente, MJ | 1 |
2 other study(ies) available for lipoxin a4 and Heart Failure
| Article | Year |
|---|---|
Effectiveness and Safety of Extracorporeal Shockwave Myocardial Revascularization in Patients With Refractory Angina Pectoris and Heart Failure.
Topics: Aged; Angina Pectoris; Angiopoietin-Like Protein 1; Angiopoietin-like Proteins; Coronary Artery Disease; Cytokines; Endothelial Progenitor Cells; Extracorporeal Shockwave Therapy; Female; Heart Failure; Humans; Interleukin-18; Interleukin-1beta; Lipoxins; Male; Middle Aged; Myocardial Perfusion Imaging; Myocardial Revascularization; Prospective Studies; Severity of Illness Index; Stroke Volume; Transforming Growth Factor beta; Treatment Outcome; Vascular Endothelial Growth Factor A; Ventricular Dysfunction, Left; Walk Test | 2021 |
Impaired resolution of inflammation in human chronic heart failure.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biomarkers; Cardiovascular Diseases; Chronic Disease; Female; Glomerular Filtration Rate; Heart Failure; Humans; Inflammation; Leukocyte Count; Lipoxins; Male; Peroxidase; Risk Factors | 2014 |